Yichen Zhu

机构：Henan Cancer Hospital · ORCID：0009-0008-9188-066X

发表论文 15 篇 · 总被引 467 次 · h-index 10

代表论文

• In vivo CAR engineering for immunotherapy (2025 · Nature reviews. Immunology · 被引 128)
• Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy (2024 · Molecular Therapy · 被引 68)
• Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application (2025 · Cell Death and Disease · 被引 58)
• Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells (2025 · Med · 被引 48)
• The clinical landscape of CAR-engineered unconventional T cells (2025 · Trends in cancer · 被引 42)
• IL-15 in CAR engineering: striking an efficacy–safety balance (2025 · Trends in Molecular Medicine · 被引 35)